Study Stopped
The study design failed and the data was not able to be analyzed.
Evaluation of the Patient Safety Screening Tool (PSST) for Sepsis
A Validation of a Patient Safety Screening Tool for Sepsis
1 other identifier
observational
221
1 country
1
Brief Summary
The Patient Safety Screening Tool (PSST) for Sepsis solution is a tool to assist with the early detection of Sepsis and management of the administration of bundle packages as defined by the Institute for Healthcare Improvement (IHI). This web based application relies on integration with bedside medical equipment (BME) data as well as Lab and Registration data so that clinical workflow items can be automated in the fight against Sepsis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 12, 2008
CompletedFirst Posted
Study publicly available on registry
June 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedApril 20, 2017
April 1, 2017
1.8 years
June 12, 2008
April 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Demonstrate a reduction in time to detection of sepsis using the PSST Alert System
6 and 24 hours
Secondary Outcomes (1)
Determine the accuracy of the PSST Alert System
6 and 24 hours
Study Arms (1)
1
Patients in the NCU at VUH
Eligibility Criteria
This study will be located in the 22 bed Vanderbilt University Medical Center Neuro Care Unit (NCU). Every patient will be screened for sepsis according to the following workflow upon admission to the NCU. The patient population of the NCU is generally bimodal; the first group consists of post-operative patients with an average length of stay of three to five days. The second group consists of subarachnoid hemorrhage patients with an average length of stay of 45 days.
You may qualify if:
- Patients that are hospitalized in the Neuro Care Unit (NCU)
- Patients that are hospitalized in the Vanderbilt Burn Center
- Patients must be \> 18 years of age
You may not qualify if:
- Patients \< 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John A Barwise, M.D.
Vanderbilt University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asssistant Professor
Study Record Dates
First Submitted
June 12, 2008
First Posted
June 17, 2008
Study Start
May 1, 2008
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
April 20, 2017
Record last verified: 2017-04